| NCT ID | NCT07338240 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital |
| Condition | Intensive Care Unit Patients |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,200 participants |
| Start Date | 2026-01-19 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,200 participants in total. It began in 2026-01-19 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate how well a new scoring system called the Sequential Organ Failure Assessment-2 (SOFA-2) works in adult intensive care units in Türkiye. SOFA-2 is designed to measure the severity of organ dysfunction in critically ill patients using routinely collected clinical and laboratory data. It is an updated version of the original SOFA score and reflects modern intensive care practices. In this multicenter observational study, adult patients admitted to participating intensive care units will be followed during their ICU stay. SOFA and SOFA-2 scores will be calculated during the first 24 hours of admission, and in patients with longer stays, additional scores will be recorded. No additional tests or treatments will be performed as part of the study. The main goal of the study is to examine the relationship between SOFA-2 scores and intensive care unit mortality. The results are expected to help clinicians better assess disease severity and outcomes in critically ill patients.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Admission to a participating intensive care unit in Türkiye * Intensive care unit stay longer than 24 hours Exclusion Criteria: * Patients younger than 18 years * Pregnant patients * Organ donors * Patients with unknown intensive care unit discharge outcomes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07338240 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intensive Care Unit Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07338240 currently recruiting?
Yes, NCT07338240 is actively recruiting participants. Contact the research team at deu.syldrm@gmail.com for enrollment information.
Where is the NCT07338240 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07338240 clinical trial?
NCT07338240 is sponsored by Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital. The trial plans to enroll 5,200 participants.